Cargando…
Evaluating somatic tumor mutation detection without matched normal samples
BACKGROUND: Observations of recurrent somatic mutations in tumors have led to identification and definition of signaling and other pathways that are important for cancer progression and therapeutic targeting. As tumor cells contain both an individual’s inherited genetic variants and somatic mutation...
Autores principales: | Teer, Jamie K., Zhang, Yonghong, Chen, Lu, Welsh, Eric A., Cress, W. Douglas, Eschrich, Steven A., Berglund, Anders E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584341/ https://www.ncbi.nlm.nih.gov/pubmed/28870239 http://dx.doi.org/10.1186/s40246-017-0118-2 |
Ejemplares similares
-
Discriminating somatic and germline mutations in tumor DNA samples without matching normals
por: Hiltemann, Saskia, et al.
Publicado: (2015) -
TOSCA: an automated Tumor Only Somatic CAlling workflow for somatic mutation detection without matched normal samples
por: Del Corvo, Marcello, et al.
Publicado: (2022) -
Iterative rank-order normalization of gene expression microarray data
por: Welsh, Eric A, et al.
Publicado: (2013) -
Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma
por: Schabath, Matthew B., et al.
Publicado: (2015) -
Characteristics and Validation Techniques for PCA-Based Gene-Expression Signatures
por: Berglund, Anders E., et al.
Publicado: (2017)